SCHOTT Pharma AG & Co. KGaA Asset Resilience Ratio

Latest as of September 2024: 0.23%

SCHOTT Pharma AG & Co. KGaA asset resilience ratio. SCHOTT Pharma AG & Co. KGaA (1SXP) has an Asset Resilience Ratio of 0.23% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 1SXP days of operational coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€3.25 Million

≈ $3.80 Million USD Cash + Short-term Investments

Total Assets

€1.44 Billion

≈ $1.69 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of SCHOTT Pharma AG & Co. KGaA (2022–2024)

Asset resilience ratio of SCHOTT Pharma AG & Co. KGaA from 2022 to 2024. This chart shows how SCHOTT Pharma AG & Co. KGaA's Asset Resilience Ratio has changed over time. Read SCHOTT Pharma AG & Co. KGaA balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down SCHOTT Pharma AG & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see SCHOTT Pharma AG & Co. KGaA (1SXP) total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€3.25 Million	0.23%
Total Liquid Assets	€3.25 Million	0.23%

Asset Resilience Insights

Limited Liquidity: SCHOTT Pharma AG & Co. KGaA maintains only 0.23% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

SCHOTT Pharma AG & Co. KGaA Industry Peers by Asset Resilience Ratio

Compare SCHOTT Pharma AG & Co. KGaA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Micro Tech Nanjing Co Ltd SHG:688029	Medical Instruments & Supplies	1.63%
QITIAN Technology Group Co Ltd SHE:300061	Medical Instruments & Supplies	0.00%
Mark Dynamics Indonesia Tbk PT JK:MARK	Medical Instruments & Supplies	6.64%
Medeon Biodesign TWO:6499	Medical Instruments & Supplies	32.68%
Crossject PA:ALCJ	Medical Instruments & Supplies	1.31%
Nyxoah BR:NYXH	Medical Instruments & Supplies	12.40%
Ansell Ltd AU:ANN	Medical Instruments & Supplies	7.53%
Nanosonics Ltd AU:NAN	Medical Instruments & Supplies	46.84%

SCHOTT Pharma AG & Co. KGaA Asset Resilience Ratio by Year (2022–2024)

SCHOTT Pharma AG & Co. KGaA asset resilience ratio by year from 2022 to 2024. The table below shows the annual Asset Resilience Ratio data for SCHOTT Pharma AG & Co. KGaA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	0.23%	€3.25 Million ≈ $3.80 Million	€1.44 Billion ≈ $1.69 Billion	+0.10pp
2023-06-30	0.12%	€1.53 Million ≈ $1.79 Million	€1.23 Billion ≈ $1.44 Billion	0.00pp
2022-06-30	0.12%	€1.49 Million ≈ $1.74 Million	€1.20 Billion ≈ $1.40 Billion	--

pp = percentage points

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$4.40 Billion

€3.77 Billion EUR

Market Cap Rank

#5363 Global

#870 in Germany

Share Price

€25.00

Change (1 day)

-1.19%

52-Week Range

€12.96 - €26.00

All Time High

€41.20